FMR LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 10:13 am Purchase | 2026-05-29 | 13G | AVALO THERAPEUTICS INC PAR AVTX | FMR LLC | 3,188,401 6.100% | 308,920 (+10.73%) | Filing |
| 2026-05-06 11:00 am Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | FMR LLC | 2,879,481 12.600% | 753,662 (+35.45%) | Filing |
| 2026-03-06 10:05 am Purchase | 2026-02-27 | 13G | AVALO THERAPEUTICS INC PAR AVTX | FMR LLC | 2,125,819 11.500% | 2,125,819 (New Position) | Filing |